ANI PHARMACEUTICALS INC (ANIP)
US00182C1036 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 221.12M | 48.20M | 100.30M | 7.90M | 62.30M | |||
| Receivables | 162.08M | 169.30M | 132.20M | 95.80M | 73.20M | |||
| Inventories | 111.20M | 105.40M | 81.70M | 60.80M | 48.20M | |||
| Other Current Assets | 25.42M | 21.40M | 7.60M | 5.90M | 4.00M | |||
| Total Current Assets | 519.82M | 344.30M | 321.80M | 170.30M | 187.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 44.59M | 43.20M | 52.70M | 41.30M | 40.60M | |||
| Goodwill | 28.22M | 28.20M | 27.90M | 3.60M | 3.60M | |||
| Intangibles | 209.01M | 251.60M | 294.10M | 188.50M | 180.40M | |||
| Other Non-Current Assets | 102.78M | 92.70M | 75.10M | 57.50M | 44.60M | |||
| Total Non-Current Assets | 384.61M | 415.80M | 449.80M | 290.90M | 269.10M | |||
| TOTAL ASSETS | 904.42M | 760.10M | 771.60M | 461.20M | 456.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 850.00K | 900.00K | 900.00K | 13.20M | 9.90M | |||
| Accrued Expenses | 57.84M | 35.90M | 27.80M | 22.90M | 20.10M | |||
| Accounts Payable | 36.68M | 29.30M | 23.00M | 11.30M | 14.60M | |||
| Other Current Liabilities | 50.11M | 33.40M | 35.90M | 31.10M | 17.00M | |||
| Total Current Liabilities | 145.48M | 99.40M | 87.50M | 78.60M | 61.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 284.82M | 285.70M | 286.50M | 172.40M | 175.80M | |||
| Other Non-Current Liabilities | 16.53M | 36.40M | 38.80M | 14.50M | 6.50M | |||
| Total Non-Current Liabilities | 301.35M | 322.10M | 325.40M | 186.90M | 182.30M | |||
| TOTAL LIABILITIES | 446.82M | 421.50M | 412.90M | 265.50M | 244.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -80.13M | -97.30M | -47.80M | -5.00M | 17.60M | |||
| Additional Paid In Capital | 514.10M | 403.90M | 387.80M | 214.40M | 200.80M | |||
| Common Shares | 24.85M | 24.90M | 24.90M | 0.00 | 0.00 | |||
| Treasury Stock | -10.08M | -5.10M | -3.10M | -2.20M | -700.00K | |||
| Other Shareholders' Equity | 8.86M | 12.20M | -3.10M | -11.40M | -4.90M | |||
| Shares Outstanding | 20.48M | 17.50M | 16.80M | 12.40M | 12.10M | |||
| Tangible Book Value per Share | 9.55 | 1.93 | 0.70 | 0.29 | 2.38 | |||
| Total Shareholders' Equity | 457.60M | 338.50M | 358.70M | 195.70M | 212.80M | |||
| TOTAL LIABILITIES AND EQUITY | 904.42M | 760.10M | 771.60M | 461.20M | 456.80M | |||
| Statistics | ||||||||
| Debt/Equity | 0.62 | 0.84 | 0.80 | 0.88 | 0.83 | |||
| Current Ratio | 3.57 | 3.46 | 3.68 | 2.17 | 3.04 | |||
| Return On Assets (ROA) | 1.71% | -6.51% | -5.55% | -4.88% | 1.31% | |||
| Return On Equity (ROE) | 3.38% | -14.62% | -11.93% | -11.50% | 2.82% | |||
| Return On Invested Capital (ROIC) | 5.01% | N/A | N/A | N/A | 4.64% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 7.07% | N/A | N/A | N/A | 5.51% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 12.64% | N/A | N/A | N/A | 12.32% | |||
All data in USD